Mustang Bio, Inc. (MBIO) — Financial statements
Income statement, balance sheet, and cash flow for Mustang Bio, Inc. — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Cost of Revenue | 0.04 | 0.00↓100.0% | 2↓26.6% | 3↑31.4% | 2 | |
| Gross Profit | -0.04 | 0.00↑100.0% | -2↑26.6% | -3↓31.4% | -2 | |
| Operating Expenses | ||||||
| R&D Expenses | 2↓82.0% | 8↓78.5% | 39↓38.7% | 64↑19.4% | 54 | |
| General & Administrative Expenses | 4↓4.5% | 4↓57.3% | 10↓20.7% | 12↑10.8% | 11 | |
| Selling & Marketing Expenses | 0.00 | 0.00↑100.0% | -0.37 | 0.00 | 0.00 | |
| SG&A Expenses | 4↓4.5% | 4↓55.6% | 9↓23.7% | 12↑10.8% | 11 | |
| Other Expenses | -3↓183.2% | 4 | 0.00↑100.0% | -3↓2080.6% | -0.14 | |
| Operating Expenses | 2↓85.3% | 16↓66.5% | 49↓33.7% | 73↑13.5% | 64 | |
| Total Costs & Expenses | 2↓85.0% | 16↓68.0% | 51↓33.4% | 76↑14.1% | 67 | |
| Operating Results | ||||||
| Operating Income | -2↑85.0% | -16↑68.0% | -51↑33.4% | -76↓14.1% | -67 | |
| Depreciation & Amortization | 0.04↓95.0% | 0.82↓63.0% | 2↓26.6% | 3↑31.4% | 2 | |
| EBITDA | -2↑84.0% | -15↑68.9% | -48↑32.4% | -71↓11.1% | -64 | |
| EBIT | -2↑84.6% | -16↑68.7% | -50↑32.2% | -74↓11.8% | -66 | |
| Interest & Other Income | ||||||
| Net Interest Income | 0.51↑170.4% | 0.19↑140.7% | -0.46↑82.6% | -3↓856.4% | 0.35 | |
| Interest Income | 0.51↑177.7% | 0.18↓78.4% | 0.85↑23.4% | 0.69↑87.2% | 0.37 | |
| Interest Expense | 0.00↑100.0% | -0.01↓100.4% | 1↓60.9% | 3↑22293.3% | 0.02 | |
| Non-Operating Income | 0.00↑100.0% | -0.50↓13.7% | -0.44↑78.0% | -2↓441.6% | -0.37 | |
| Other Income / Expenses | 0.51↑3.7% | 0.49↑156.3% | -0.88↑35.9% | -1↓487.0% | 0.35 | |
| Income Before Tax | -2↑87.8% | -16↑69.5% | -52↑33.4% | -78↓16.8% | -66 | |
| Income Tax Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | -2↑87.8% | -16↑69.5% | -52↑33.4% | -78↓16.8% | -66 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | -2↑87.8% | -16↑69.5% | -52↑33.4% | -78↓16.8% | -66 | |
| Bottom-Line Net Income | -2↑87.8% | -16↑69.5% | -52↑33.4% | -78↓16.8% | -66 | |
| EPS (Basic) | -0.39↑84.8% | -2.57↑57.2% | -6.00↑46.7% | -11.25↑1.3% | -11.40 | |
| EPS (Diluted) | -0.39↑84.8% | -2.57↑57.2% | -6.00↑46.7% | -11.25↑1.3% | -11.40 | |
| Weighted Average Shares | 5↓19.9% | 6↓28.8% | 9↑24.8% | 7↑17.7% | 6 | |
| Weighted Average Diluted Shares | 5↓19.9% | 6↓28.8% | 9↑24.8% | 7↑17.7% | 6 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.